Klinikum Hanau GmbH

Hanau 9 trials 5 recruiting

9 Registered trials

5 Currently recruiting

Organisation

Klinikum Hanau GmbH

Location

Hanau, Germany

Identifier

ORG-100016439

Address

Leimenstrasse 20, 63450, Germany

Departments

Frauenklinik
Gynäkologie und Geburtshilfe
Gynecology and Obstetrics
Hematology
Klinik für Gynäkologie und Geburtshilfe
Medizinische Klinik 2
Medizinische Klinik III

Clinical trials at this site (9)

Search interface

A randomized, open-label, phase II trial comparing neoadjuvant endocrine therapy in combination with trastuzumab, pertuzumab +/- the PI3K in… Recruiting

2022-501152-28-00 Breast Cancer 4 2022-12-21
Evaluation of Niraparib alone compared to the combination of Niraparib and Bevacizumab in patients receiving chemotherapy for newly diagnose… Recruiting

2024-516066-11-00 Patients with newly diagnosed, histologically confirmed 5 2022-08-31
Pembrolizumab in combination with lenvatinib in patients with recurrent, persistent, metastatic or locally advanced vulvar cancer not amenab… Recruiting

2024-515646-16-00 Recurrent, persistent, metastatic or locally advanced v 4 2025-06-24
CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCE… Recruiting

2022-500764-35-00 Patients with advanced HER2-negative, hormone receptor 6 2022-10-13
Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy Recruiting

2022-500107-50-00 hilar cholangiocarcinoma 6 2022-10-12
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
HD21 Ended

2024-518022-33-00 Advanced Stage of Hodgkin Lymphoma 5 2016-07-15